BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: McCudden C, Akbari A, White CA, Biyani M, Hiremath S, Brown PA, Tangri N, Brimble S, Knoll G, Blake PG, Sood MM. Individual patient variability with the application of the kidney failure risk equation in advanced chronic kidney disease. PLoS One 2018;13:e0198456. [PMID: 29894480 DOI: 10.1371/journal.pone.0198456] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Mutatiri C, Ratsch A, McGrail MR, Venuthurupalli S, Kondalsamy Chennakesavan S. Referral patterns, disease progression and impact of the kidney failure risk equation (KFRE) in a Queensland Chronic Kidney Disease Registry (CKD.QLD) cohort: a study protocol. BMJ Open 2022;12:e052790. [PMID: 35193907 DOI: 10.1136/bmjopen-2021-052790] [Reference Citation Analysis]
2 Christofides EA, Desai N. Optimal Early Diagnosis and Monitoring of Diabetic Kidney Disease in Type 2 Diabetes Mellitus: Addressing the Barriers to Albuminuria Testing. J Prim Care Community Health 2021;12:21501327211003683. [PMID: 33749371 DOI: 10.1177/21501327211003683] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
3 Bull LM, Lunt M, Martin GP, Hyrich K, Sergeant JC. Harnessing repeated measurements of predictor variables for clinical risk prediction: a review of existing methods. Diagn Progn Res 2020;4:9. [PMID: 32671229 DOI: 10.1186/s41512-020-00078-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
4 Leon SJ, Tangri N. The Use of Renin-Angiotensin System Inhibitors in Patients With Chronic Kidney Disease. Can J Cardiol 2019;35:1220-7. [PMID: 31472818 DOI: 10.1016/j.cjca.2019.06.029] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]